| Species : | Human | 
                                
                                    | Source : | CHO | 
                                
                                    | Tag : | Avi&Fc | 
                                
                                    | Protein Length : | Leu25-Thr168 | 
                                
                                    | Description : | Programmed Death-1 receptor (PDCD1), also known as CD279, is type I transmembrane protein belonging to the CD28 family of immune regulatory receptors (1). Other members of this family include CD28, CTLA-4, ICOS, and BTLA (2-5). Mature mouse PDCD1 consists of a 149 amino acid (aa) extracellular region (ECD) with one immunoglobulin-like V-type domain, a 21 aa transmembrane domain, and a 98 aa cytoplasmic region. The mouse PDCD1 ECD shares 65% aa sequence identity with the human PD-1 ECD. The cytoplasmic tail contains two tyrosine residues that form the immunoreceptor tyrosine-based inhibitory motif (ITIM) and immunoreceptor tyrosine-based switch motif (ITSM) that are important for mediating PDCD1 signaling. PDCD1 acts as a monomeric receptor and interacts in a 1:1 stoichiometric ratio with its ligands PD-L1 (B7-H1) and PD-L2 (B7-DC) (6, 7). PD-1 is expressed on activated T cells, B cells, monocytes, and dendritic cells while PD-L1 expression is constitutive on the same cells and also on nonhematopoietic cells such as lung endothelial cells and hepatocytes (8, 9). Ligation of PD-L1 with PD-1 induces co-inhibitory signals on T cells promoting their apoptosis, anergy, and functional exhaustion (10). Thus, the PD-1:PD-L1 interaction is a key regulator of the threshold of immune response and peripheral immune tolerance (11). Finally, blockade of the PD-1: PD-L1 interaction by either antibodies or genetic manipulation accelerates tumor eradication and shows potential for improving cancer immunotherapy (12, 13). | 
                                
                                    | Predicted N Terminal : | Leu25 | 
                                
                                    | Form : | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. | 
                                
                                    | Bio-activity : | Measured by its binding ability in a functional ELISA. When Recombinant Human PDCDL1 Fc Chimera is immobilized at 1 μg/mL (100 μL/well), the concentration of Biotinylated Recombinant Human PDCD1 Fc Chimera Avi-tag that produces 50% of the optimal binding response is 10-90 ng/mL. | 
                                
                                    | Molecular Mass : | 62-88 kDa, under reducing conditions | 
                                
                                    | Endotoxin : | <0.10 EU per 1 μg of the protein by the LAL method. | 
                                
                                    | Purity : | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. | 
                                
                                    | Applications : | Bioactivity | 
                                
                                    | Storage : | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied.1 month, 2 to 8 °C under sterile conditions after reconstitution.3 months, -20 to -70 °C under sterile conditions after reconstitution. | 
                                
                                    | Reconstitution : | Reconstitute at 250 μg/mL in PBS. | 
                                
                                    | Conjugation : | Biotin |